PeptideStack
5.2kquestions
20kanswers
220users

What should I make of a liraglutide documentation package that has no list of related substances?

Asked 3 Nov 2025Modified 5 months agoViewed 20k times
27

The particulars: liraglutide · list of related substances.

I want to understand what this actually establishes, as opposed to what it is being used to imply.

My concern is that I am being invited to draw a conclusion the data does not support.

Which parts of this are informative and which are decoration?

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
liraglutide
liraglutide

A once-daily GLP-1 receptor agonist and the compound that established the class. Still relevant for its shorter half-life, its paediatric and…

235 questions
shareeditfollowflag
AZ
askedahmed_zerouali15k173 Nov 2025

5 Answers

Accepted answer first, then by votes
29

Accepted answer

A useful certificate has five elements: the lot number, the analytical method, the reported result with units, the date of analysis, and the primary data or a reference to it.

The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.

The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.

Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.

The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

shareimprove this answerflag
AL
answered · accepteda_lindgren58k24814 Dec 2025
2The distinction between purity and content cannot be repeated often enough here. – coldpack_88 8 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
34

Ask whether the certificate answers the question you are actually asking, because the answer is often no.

Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.

Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.

The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.

Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.

If the certificate does not trace to your vial, it is not evidence about your vial.

edited 9 Jan 2026 by j_wierzbicki — corrected a unit error in the worked example

shareimprove this answerflag
JW
answeredj_wierzbicki69k1485 Jan 2026
23

Specifically, reading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.

Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.

Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.

One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.

My working rule is that a document without a lot number, a method section and a test date is marketing.

edited 10 Jan 2026 by nkem_obiora — added the method parameters

shareimprove this answerflag
NO
answerednkem_obiora39k3825 Dec 2025
13

The most common trap is reading a certificate as if it were a guarantee when it is actually a single point estimate from a single test.

Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.

Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.

If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.

shareimprove this answerflag
FV
answeredfill_volume22k383 Dec 2025
2Small correction: the limit of quantitation, not the limit of detection, is the relevant one there. – t_oyelaran 10 months ago
Two of us submitted the same lot to different laboratories and got results a tenth apart. – birk_nordahl 8 months ago
add a comment
10

What makes a certificate useful is not its appearance but whether you could hand it to another laboratory and they would reproduce the result.

A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.

Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.

In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.

shareimprove this answerflag
EM
answeredeoin_mcgarry18k3819 Feb 2026
7The system-suitability data is the part that tells you whether to believe the rest. – kelvin_lam 8 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.